This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
08/28/15 - 3:58:44 PM ET (BATS BZX Real-time Price)
Div Yield: --
OGEN Day's Range
OGEN 52 Week Range
OGEN Business Summary
Oragenics, Inc. develops, markets, and sells oral probiotics products and antibiotics for humans and companion pets.View OGEN key stats
Oragenics Inc - OGEN - EQUITY
Reviewed By: TheStreet Ratings on .
Report Summary: TheStreet Ratings team rates Oragenics Inc as a
Sell with a ratings score of D-.
Report Snippet: We rate ORAGENICS INC (OGEN) a SELL. This is driven by multiple weaknesses, which we believe should have a greater impact than any strengths, and could make it more difficult for investors to achieve positive results compared to most of the stocks we cover. The area that we feel has been the company's primary weakness has been its disappointing return on equity.